Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Place your order with Schwab. They'll take it. No idea whether your $.002 limit offer will get filled though.
It's just my opinion, of course, but anyone who would buy shares in a Company with a CEO who has dropped out of sight isn't being very smart.
"I own Brilacidin and some BeaMed."
At this point you can't be sure of that (https://www.sec.gov/cgi-bin/browse-edgar?company=innovation+pharmaceuticals) and even if you could there's no hard evidence to show that they are worth owning. Even before this latest slip into the abyss of the Expert Market investors as a group couldn't move this thing past two cents.
I'm not obsessed with Leo but his actions and failures to act of late have been hard to ignore.
"Company leaders can be replaced.
Any person in a company can be replace."
Idle chatter.
How would you suggest that that could be done exactly?
"This article is a preprint and has not been certified by peer review"
But let's say that it was. Who's gonna run the trial?
"Back in the day I accused you of beating and beating and beating the Dead horse."
But I was right about the horse. And now you're admitting that it was dead.
"Maybe the Sec/finra will investigate you and your Cabal."
Nonsense. The truth is a very strong defense and we're all entitled to our opinions. Even you.
Here's the truth as of 4:00PM Eastern yesterday:
IPIX
Innovation Pharmaceuticals Inc (CE) (IPIX) Quote
0.003
(note: the CE designation is a copy and paste from https://ih.advfn.com/stock-market/USOTC/innovation-pharmaceuticals-ce-IPIX/stock-price )
You can lay the blame for THAT truth at the doorstep of those who have been wrong for the last dozen years or so.
http://www.ipharminc.com/senior-management
http://www.ipharminc.com/board-of-directors
Don't blame me.
Same questions:
Where's Leo?
"The Brazil team is busy."
"The Israel team remain in schedule to ask USA FDA early June for approvals to sell their new system."
You make things sound good. Seems an odd time for a CEO to disappear without a trace, doesn't it?
What will it take for you to stop dispensing hope where none is warranted?
"Today for the first time in well over a year I got some useful data from this website."
Not from IPIX you didn't....a lack of current information explains their $.00X share price and their appearance on the inaptly called "Expert Market".
And today for the first time in over a year you saw fit to comment. Did you not see the passing on of Kevetrin and the IPIX cash balance as useful data worthy of comment?
Just a suggestion.
"For now the price and trade of Ipix sleeps."
https://www.facebook.com/MontyPython/videos/monty-python-dead-parrot/1041033669786167/
Where's Leo?
"The Brazil team is busy."
"The Israel team remain in schedule to ask USA FDA early June for approvals to sell their new system."
You make things sound good. Seems an odd time for a CEO to disappear without a trace, doesn't it?
What will it take for you to stop dispensing hope where none is warranted?
"Could have sworn Barry Schechter and Zorik Spektor were both removed from the page."
They weren't. You're not suggesting that they are still on the Board, are you?
Do you think Leo Ehrlich is still CEO?
Could you have sworn that he was removed from the page as well? There hasn't been a filing reporting his resignation.
http://www.ipharminc.com/board-of-directors
" ever question why 200k shares were just purchased?"
I figured you or one of the other loyalists stumbled over $460 in nickels in your couch cushions.
That size buy doesn't exactly scream "accredited investor".
"and now she is gone."
It LOOKS that way, but this cloak of silence that LE has donned leaves us guessing.
She (and he) could be continuing to collect their regular checks and just erasing their public connections to IPIX.
Did LE leave the Company checkbook behind?
Jane Harness
Company name has been changed....in this case deleted....to try to protect a badly soiled reputation.
Guess she learned the benefits of scrubbing from her mentor.
Experience
Clinical Research & Project Management Consultant
2016 - Present · 8 yrs 4 mos
MA, USA
Vice President, Clinical OperationsVice President, Clinical Operations
Revance Therapeutics, Inc.Revance Therapeutics, Inc.
2014 - 2015 · 1 yr2014 - 2015 · 1 yr
Newark, CA, USANewark, CA, USA
Head of Clinical Sciences, Dermatology & ATI Translational Research
Novartis Institutes for BioMedical ResearchNovartis Institutes for BioMedical Research
2010 - 2014 · 4 yrs
Basel, SwitzerlandBasel, Switzerland
Clinical Lead/ Director
Pfizer
2002 - 2010 · 8 yrs
Led the overall clinical development of multiple Dermatology programs, oral and topical.Led the overall clinical development of multiple Dermatology programs, oral and topical.…see more
Note "2016 - Present"
Somebody bought em and somebody sold em, no?
More likely someone decided to take their $4-5k and go home.
Probably a smart move.
fb?
"Leo told us about the BoD leaving but nothing on Jane and the last hire? Strange"
Are you serious? Leo didn't even tell us about Leo.
The Director resignations required a filing and that happened on 2/1. Jane's situation does not.
Leo didn't file the 10Q or the Lateness Notification which was due on 2/15.
If Leo resigned any of his positions he was obligated to submit a filing saying so but he has done the most irresponsible thing he could possibly do.....disappear without a peep.
Frenchbroad is still around and reading the board. Speechless I guess....I know that I would be.
https://ih.advfn.com/stock-market/USOTC/innovation-pharmaceuticals-ce-IPIX/stock-price
Obviously I can only answer for myself:
Do you really think that a judgment against the Company for more cash than it has, the resignation of both independent Directors, the relegation of the Company's shares to the Expert Market making them barely tradable and the literal disappearance of the CEO makes IPIX LESS interesting? Because it doesn't. And I'd like to see how those things play out.
For me the risk of hanging around is negligible.
I believe the Ignore feature is still functional. If the truth hurts you might want to use it.
By the way, regarding "if it's game over like you say it is" I never said that it was, but there aren't too many good reasons to think that it isn't.
"Finally bankruptcy. BUT, I never sold my 6 million shares. Some entity since then paid off the bills and the judge ruled the company free and clear. It's a clean shell with a low share structure hanging there ripe for a merge."
So you still have your 6 million shares of a Company that filed bankruptcy?
What's the name of that example Company?
"The appeal of the judgment against IPIX is due to be filed on May 8 "
Is that what this means?
"Review Appeals Filed 03/11/2024 05/08/2024"
I read the article that you couldn't link but Pipi could.
It's just the same old rubbish.
Demand for shells and equities is going up at a blistering pace (zero support offered).
"Supply in global equities is shrinking" according to a link that didn't work.
Massive short covering of huge naked short position.
Fairy Tales.
But did you see how that precipitous drop came about?
There were only 2 trades reported.
At 11:30 167,235 exchanged hands at $.011.
At 12:12 1,400 went thru at $.0042.
microchips has it right when they write that that is "the way it works when there is no real market". Those two trades could just as easily have gone off in the opposite order and some would think that it was party time.
It's a meaningless change, except it stands as a good example of how different things are for investors wanting to buy or sell compared to 3 days ago.
Again? He couldn't reference it the first time.
Who's gonna do the piercing? I sense no outrage here.
You know things are bad for a company when the class action shysters let them slide.
edit: There's always the derivative suit.
"A shareholder derivative suit is a lawsuit brought by a shareholder on behalf of a corporation against a third party. Often, the third party is an insider of the corporation, such as an executive officer or director."
Don't hold your breath for that either.
Good question, because I think the disappearing act may turn your trigger event into a gray area...and that may have been one of the reasons for it. The details of a filing would confirm that a trigger event had occurred.
Here's the impact of a trigger event:
" 5.3 Termination by Penn.
Penn may terminate this Agreement on written notice to Licensee if any of the following events of default (“Default”) occur:"
"5.3.2 Licensee experiences a Trigger Event;"
But why would private party Leo pay a judgment against public Company IPIX?
"Through the date of this report, management has been unable to secure additional financing, and the ability of the Company to continue as a going concern is becoming increasingly unlikely."
That language should have been scary enough, especially since it was totally voluntary. This CEO doesn't have any history of willingly being the bearer of bad news except until AFTER things happen.
The going concern thing is somewhat of a technicality but once it appears that a company is no longer a going concern (and that loosely defined standard was met by the court decision, which required funds in excess IPIX's available cash) the financials are supposed to be reported at liquidation value, which would include investments (BeaMed) and unamortized Patent Costs. The BeaMed numbers have already been raised as questionable based on lack of accounting controls as acknowledged in the last set of filings.
It COULD be that the effect of the going concern issue on the financials is why LE decided not to file the most recent set. It's starting to look like we might not hear from him again. If he disappears without an exit filing (resignation from management and the BOD) that would represent a new low from a CEO who has already had a few ugly lows.
"Below is a study of a Kevetrin modification which reportedly increase its effectiveness 100X."
"In the present study, we designed and synthesized a novel analog (compound 900) of Kevetrin"
"Drug analogs, also known as structural analogs and chemical analogs, are compounds that have a structure similar to another compound but differ from it in certain components, such as functional groups or substructures."
https://www.bocsci.com/resources/what-are-drug-analogues.html
Is it proper to call the designed novel analog compound 900 "a Kevetrin modification" when it's actually a compound that has structure similar to Kevetrin but differs from it? If compound 900 was to be approved someday the approved compound would be described by its own structure and without language describing it as a Kevetrin modification, correct?
If this is true....
"The new analog 900 is >100 fold more potent than Kevetrin and holds great promise to be developed further for ovarian and other mechanistically relevant cancers"
.....then this may not be a reasonable belief:
"I do not believe the Kevetrin story is over"
IPIX has already raised the white flag over its kevetrin development. Obviously the drug itself hasn't disappeared but its benefit to IPIX investors, such as it was, seems to be history.
"The last10q Leo filed warned we could lose our status so maybe was planned who knows. "
Here's the last 10-Q:
https://www.sec.gov/Archives/edgar/data/1355250/000147793223008688/ipix_10q.htm#a13
On what page does Leo issue that warning? I don't think it's in there.
I believe you are thinking of the 10-K filed prior to that 10-Q and that warning concerned something entirely different:
"We may elect to deregister our common stock under the Exchange Act and suspend our reporting obligations. Such deregistration and suspension would result in less disclosure about us and may negatively affect the liquidity and trading prices of our common stock."
https://www.sec.gov/ix?doc=/Archives/edgar/data/1355250/000147793223007158/ipix_10k.htm
Electing to deregister a Company's shares (which was not done here) in order to suspend reporting obligations is 180 degrees from knowingly and intentionally failing to meet a Company's filing obligations. The former requires a filing certifying that the Company meets the standards to deregister while the latter results from the willful failure to perform a legal obligation.
"Didn’t IpIx already sell/lose the rights to kevetrin?"
Neither, but with the same effect.....
From the last 10-K:
"At any time, we may decide to discontinue the development of, or to not commercialize, a drug candidate, such as our decision in December 2018 to discontinue the Prurisol psoriasis program, and our decision in September 2022 to discontinue the Kevetrin oncology program."
There's a risk-free way you can find out if people can buy it assuming you have an online brokerage account.
Enter an order to buy 100 shares. You SHOULD get a screen that asks you to click CONFIRM or CANCEL so you can avoid placing an order if that's your choice. But before you reach that point you might get a note advising that the shares are traded in the Expert Market and describing your options.
Not me. I listened to the words of wisdom of olden_grumpini:
"People should investigate how their trading platform will handle trading in IPIX shares if they are restricted to the Expert Market."
For less than 10 bucks I'm gonna find out just how Schwab does "Expert Market". I'll bet it turns out to be a helluva lot easier than asking them would have been. In terms of a use of my time and aggravation cost the investment is almost certain to have been cheaper.
Besides, the BeaMed ownership alone should guarantee me a double if Charlie S can find me a buyer :o)
And here it is. Now what?
https://www.otcmarkets.com/stock/IPIX/overview
"Warning! This security is eligible for Unsolicited Quotes Only
This stock is not eligible for proprietary broker-dealer quotations. All quotes in this stock reflect unsolicited customer orders. Unsolicited-Only stocks have a higher risk of wider spreads, increased volatility, and price dislocations. Investors may have difficulty selling this stock. An initial review by a broker-dealer under SEC Rule15c2-11 is required for brokers to publish competing quotes and provide continuous market making.
Warning! This security is traded on the Expert Market
The Expert Market® serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing. OTC Markets Group may designate securities for quoting on the Expert Market when it is not able to confirm that the company is making current information publicly available under SEC Rule 15c2-11, or when the security is otherwise restricted from public quoting."
FOMO is real!!!
Don't miss out! I made eighteen and a half cents on my holding in just 4 hours today. I should be able to book that if I can find an accredited investor to sell all 100 shares to tomorrow. Or if I was to see the same results every day for a month and a half I'd be able to cover today's commission. That would require better than a triple of today's share price, but you know what Judy Tenuta used to say about the most unlikely of possibilities....
I could resist no longer. Couldn't stand to see you guys having all the fun.
IPIX Filled Buy 100 Limit $0.02 Day $0.01585 11:55 AM 04/16/2024 11:55 AM 04/16/2024 0.0152 0.0162 0.0158
My only regret is the $6.95 that Schwab nicked me for an OTC company trade.
But will I be able to sell tomorrow?
"Although I wish it were true this report appears to be bogus."
Bogus is too kind:
"and Innovation Pharmaceuticals Inc. reporting revenue in the millions"
I wonder what Bill DeGrado thinks about IPIX screwing up his wonder drug? Maybe he could be your next CEO.
Are you saying that you need PJ's help to post a link? That's rich.
He still hasn't.
I have no interest in your OTC chatter. At this point IPIX is barely on the OTC anyway.
Can you tell us what will happen after tomorrow? Will any new investors be able to buy shares or will existing holders be forced to swap shares amongst themselves at unquoted prices? That's the way it looks to me. Have you asked your broker?
"Yes, Last Day of Grace Period: 04/16/2024"
https://www.otcmarkets.com/stock/IPIX/quote
I goigled "Twitter #OTCSET" and I got nothing that made sense:
https://www.google.com/search?q=%22Twitter+%23OTCSET%22&sca_esv=e61ceee022fb5976&sxsrf=ACQVn0_pxNRFYokrwGDSestcZESgpyAVXw%3A1713144994822&source=hp&ei=ooQcZpz0L_WoptQPm8Cp6As&iflsig=ANes7DEAAAAAZhySsiog1tlmKbX_Lsg3yczAzm0xZfHd&ved=0ahUKEwiczfO2isOFAxV1lIkEHRtgCr0Q4dUDCBc&uact=5&oq=%22Twitter+%23OTCSET%22&gs_lp=Egdnd3Mtd2l6IhEiVHdpdHRlciAjT1RDU0VUIjIFECEYoAEyBRAhGKABSKUNUABYAHAAeACQAQCYAU-gAU-qAQExuAEDyAEA-AEC-AEBmAIBoAJgmAMAkgcBMaAHxgE&sclient=gws-wiz
I wasn't surprised.
Please talk about the Company a little bit. Is it thriving? Will there be revenues in the next filing? Will there be another filing?
Or I suppose you can continue to avail yourself of the rules that now support your ability to address your analyses of other posters, some of whom focus on the Company itself.
Just a little bit of on topic discussion. Please.
What are you saying?